David Botstein
66Patents
16h-index
68Co-inventors
87Inventor score
Filing activity: Feb 28, 1983 → Jun 15, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7332280B2 | Classification of patients having diffuse large B-cell lymphoma based upon gene expression | Chemistry; Metallurgy | 77 | Expired |
| US6635468B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 66 | Expired |
| US7189530B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Chemistry; Metallurgy | 37 | Expired |
| US7390879B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Chemistry; Metallurgy | 36 | Expired |
| US4661454A | GAL1 yeast promoter linked to non galactokinase gene | Emerging Cross-Sectional Technologies | 35 | Expired |
| US6913919B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 33 | Expired |
| US6936436B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Chemistry; Metallurgy | 32 | Expired |
| US7026448B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Chemistry; Metallurgy | 30 | Expired |
| US5108901A | Tissue plasminogen activator having zymogenic or fibrin specific properties | Human Necessities | 26 | Expired |
| US5139936A | Use of the GAL1 yeast promoter | Emerging Cross-Sectional Technologies | 25 | Expired |
| US7074592B2 | Secreted and transmembrane polypeptides nucleic acid encoding | Chemistry; Metallurgy | 25 | Expired |
| US6974689B1 | Nucleic acid encoding PRO211 polypeptides | Chemistry; Metallurgy | 24 | Expired |
| US7087738B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 21 | Expired |
| US7118853B2 | Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors | Human Necessities | 21 | Expired |
| US7018811B2 | Nucleic acids encoding PRO189 polypeptides | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5262170A | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells | Human Necessities | 18 | Expired |
| US6974696B2 | PRO853 nucleic acids | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5405771A | Tissue plasminogen activator having zymogenic or fibrin specific properties | Human Necessities | 12 | Expired |
| US7189529B2 | PRO792 nucleic acids | Chemistry; Metallurgy | 12 | Expired |
| US7399834B2 | Anti-PRO1558 antibodies | Chemistry; Metallurgy | 12 | Expired |
| US7098312B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Chemistry; Metallurgy | 12 | Expired |
| US5616486A | Tissue plasminogen activator having zymogenic or fibrin specific properties | Human Necessities | 11 | Expired |
| US5520913A | Tissue plasminogen activator having zymogenic properties | Human Necessities | 10 | Expired |
| US7094567B2 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5677153A | Methods for modifying DNA and for detecting effects of such modification on interaction of encoded modified polypeptides with target substrates | Chemistry; Metallurgy | 10 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.